Literature DB >> 6627691

Primary hypothyroidism with grossly elevated plasma total thyroxine and triiodothyronine levels.

G J Beckett, J A Todd, G J Hughes, I W Campbell.   

Abstract

In an elderly patient with clinical primary hypothyroidism and a raised basal TSH, the serum free thyroxine (fT4), total thyroxine (TT4) and triiodothyronine (TT3) were consistently and paradoxically grossly elevated when measured by radioimmunoassay. In part these hormone levels were due to a high titre of endogenous IgG immunoglobulins which bound T4, T3 and reverse T3 (rT3) and thus caused gross interference in the radioimmunoassays. However, when this methodological interference was removed by using a methanolic extract of the patient's serum, the concentrations of TT4 and TT3 were still grossly elevated. It was only when basal TSH and the concentration of fT4 and fT3 were measured by equilibrium dialysis that these hormone levels were found to be consistent with primary hypothyroidism.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6627691     DOI: 10.1111/j.1365-2265.1983.tb00002.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  4 in total

Review 1.  Circulating thyroid hormone autoantibodies.

Authors:  S Benvenga; F Trimarchi; J Robbins
Journal:  J Endocrinol Invest       Date:  1987-12       Impact factor: 4.256

2.  Primary hypothyroidism with paradoxically elevated plasma thyroxine due to thyroxine-binding antibody.

Authors:  R V Hague; S P Higgins; W J May
Journal:  Postgrad Med J       Date:  1986-09       Impact factor: 2.401

3.  False elevation of serum thyroxine in myxoedema due to thyroxine-binding autoantibodies. A diagnostic pitfall.

Authors:  G P Archbold; H J Southgate; J D Teale; V Marks
Journal:  Ulster Med J       Date:  1986-04

4.  Anti-thyroxine antibodies in autoimmune thyroiditis--effect on radioimmunoassay and binding characteristics.

Authors:  B Y Cho; S J Choe; C S Koh; M Lee
Journal:  Korean J Intern Med       Date:  1986-01       Impact factor: 2.884

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.